Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for?
نویسندگان
چکیده
Despite years of enquiry and thousands of publications, best practice in the management of unstable coronary disease remains uncertain. In particular, is it best to adopt a practice of routine early catheterization with revascularization as appropriate (a socalled, ‘invasive strategy’), or restrict catheterization and revascularization to those with evidence of spontaneous or inducible ischaemia (a so-called, ‘conservative strategy’)? It is well known that patterns vary widely, especially from country to country, but it remains unclear what effect this has on outcome, if any. Over the last few years four large trials have specifically addressed this question and have given apparently conflicting results. In this issue, Janzon et al. present an economic analysis of the well-known FRISC II invasive trial which represents the first economic analysis of any such trial to be published. The results of the FRISC II invasive trial are well known. In short, 2457 patients with non-Q wave acute coronary syndromes were treated with dalteparin for 5–7 days and then randomized to an invasive or a conservative strategy (as well as to ongoing dalteparin or placebo). At 1 year, the rate of death or MI was significantly lower in the invasive group than in the conservative group (10·4% vs 14·1%, P=0·005). Janzon et al. present a detailed analysis of the costs incurred by the actual patients in the trial over 1 year using data collected prospectively. They obtain a cost of SEK201622 (22427 Euros according to the exchange rate on 20.02.01) for the invasive strategy and SEK177746 (19771 Euros) for the conservative strategy, a difference of SEK23876 (2655 Euros) or 13%, all over 1 year. These data in turn generate an incremental cost effectiveness ratio of SEK1404000 (156174 Euros) per life saved and SEK645000 (71746 Euros) per life saved or MI averted for the invasive strategy compared with the conservative strategy.
منابع مشابه
CARDIOVASCULAR MEDICINE Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial
Background: In unstable coronary artery disease short term treatment with low molecular weight heparin in addition to aspirin has been shown to be effective. Objective: To assess the cost effectiveness of extended treatment with dalteparin in patients managed with a non-invasive treatment strategy. Design: Prospective, randomised, multicentre study. Setting: 58 centres in Sweden, Denmark, and N...
متن کاملCost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial.
BACKGROUND In unstable coronary artery disease short term treatment with low molecular weight heparin in addition to aspirin has been shown to be effective. OBJECTIVE To assess the cost effectiveness of extended treatment with dalteparin in patients managed with a non-invasive treatment strategy. DESIGN Prospective, randomised, multicentre study. SETTING 58 centres in Sweden, Denmark, and...
متن کاملMolecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.
Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...
متن کاملEarly angiography in patients with chronic kidney disease: a collaborative systematic review.
BACKGROUND AND OBJECTIVES In the general population, an early invasive strategy of routine coronary angiography is superior to a conservative strategy of selective angiography in patients who are admitted with unstable angina or non-ST segment elevation myocardial infarction (MI), but the effectiveness of this strategy in individuals with chronic kidney disease (CKD) is uncertain. DESIGN, SET...
متن کاملThe effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model.
OBJECTIVE To determine the effectiveness and cost-effectiveness of a range of strategies based on conventional clinical information and novel circulating biomarkers for prioritising patients with stable angina awaiting coronary artery bypass grafting (CABG). DATA SOURCES MEDLINE and EMBASE were searched from 1966 until 30 November 2008. REVIEW METHODS We carried out systematic reviews and m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European heart journal
دوره 23 1 شماره
صفحات -
تاریخ انتشار 2002